UK markets close in 7 hours 57 minutes

Actinium Pharmaceuticals, Inc. (ATNM)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
8.84-0.12 (-1.34%)
At close: 04:00PM EDT
8.84 0.00 (0.00%)
After hours: 05:16PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-30,380
-48,818
-33,017
-24,774
-22,215
Depreciation & amortisation
675
790
699
524
447
Stock-based compensation
2,264
3,842
2,795
1,694
1,254
Change in working capital
38,811
-3,149
38,167
1,690
-1,103
Other working capital
11,020
-47,488
8,278
-20,999
-21,870
Net cash provided by operating activities
11,370
-47,335
8,644
-20,866
-21,617
Cash flows from investing activities
Investments in property, plant and equipment
-350
-153
-366
-133
-253
Net cash used for investing activities
-350
-153
-366
-133
-253
Cash flows from financing activities
Debt repayment
-70
-4
-49
-85
-460
Common stock issued
19,087
14,612
23,158
35,300
76,589
Net cash used provided by (used for) financing activities
19,017
14,870
23,109
35,221
76,176
Net change in cash
30,037
-32,618
31,387
14,222
54,306
Cash at beginning of period
82,472
109,608
78,221
63,999
9,693
Cash at end of period
112,509
76,990
109,608
78,221
63,999
Free cash flow
Operating cash flow
11,370
-47,335
8,644
-20,866
-21,617
Capital expenditure
-350
-153
-366
-133
-253
Free cash flow
11,020
-47,488
8,278
-20,999
-21,870